Levetiracetam plus Oxcarbazepine Combination Treatment Downregulates Serum Multidrug Resistance Protein 1 Levels and Upregulates Neuropeptide Y Levels in Children with Epilepsy. Braz. J. Pharm. Sci. 2023;59:e21414. doi:10.1590/s2175-97902023e21414